article thumbnail

Biopharma struggling to find talent with adequate digital skills

European Pharmaceutical Review

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

article thumbnail

Innovation key for boosting UK biopharma competitiveness

European Pharmaceutical Review

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

University of Oklahoma to open bioprocessing training facility

European Pharmaceutical Review

Siddique noted that four of the state’s biggest biopharma companies will be located close to the site. The EDA will also finance five more Oklahoma-based projects: Biomanufacturing Workforce Training Center. OU Health Stephenson Cancer Center for Therapeutics – Translational Research Labs. Oklahoma Bioscience Cluster Initiative.

article thumbnail

Eurofins BPT Cell Banking certified by global regulatory agencies

PharmaTech

Eurofins BioPharma Product Testing in Lancaster, PA, is a leader in ensuring the quality and safety of cell banks used in biomanufacturing. We employ controlled processes, including employee training and contamination control, to maintain quality.

article thumbnail

How resilient is the global biopharma industry?

Pharmaceutical Technology

As the full consequences of the COVID-19 virus started to emerge, and many industries found themselves having to either suspend operations or move to remote working, the biopharma sector found itself on the front line facing unprecedented challenges. R&D ecosystem - Index score 6.54/10.

article thumbnail

The Pillars of Trust: Regulatory Compliance in Patient Engagement

PM360

No training in the world can make up for a lack of the security and automation features that make regulatory compliance even possible. With healthcare professionals becoming less accessible to biopharma reps, the emphasis has shifted toward patient empowerment.

article thumbnail

New medicines manufacturing centre to enhance UK talent

European Pharmaceutical Review

It will build on existing infrastructure and best practice, and deliver sustainable, end-to-end training provision. Last month in late August 2023, another round of funding to help boost the UK medicines manufacturing sector and support innovation in the biopharma industry was announced.